An Institutional Summary of Incidence and Risk of Second Primary Cancer (SPC) after Treatment for Papillary Thyroid Carcinoma (PTC)
Differentiated thyroid cancer (DTC) is the most common endocrine malignancy, accounting for 2.9% of new cancer cases. Decreased mortality and longer survival raise concern for development of SPC. Studies cite up to a 10% rate of SPC after DTC, with increased incidence of SPC among patients with PTC. Radioactive iodine therapy (RAIT) is implicated as a potential reason for SPC. We aimed to determine the incidence of SPC, associated mortality, and relationship with RAIT.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Heba Elassar, Jordan Reilly, Morta Lapkus, Jacquelyn Pastewski, Diane Studzinski, Fionna Sun, Erfan Faridmoayer, Peter F. Czako, Sapna Nagar Tags: Endocrine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Iodine | Jordan Health | Middle East Health | Study | Surgery | Thyroid | Thyroid Cancer